Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Change in Receivables (2016 - 2018)

Kraig Biocraft Laboratories (KBLB) has disclosed Change in Receivables for 3 consecutive years, with -$99256.0 as the latest value for Q4 2018.

  • Quarterly Change in Receivables fell 7252.3% to -$99256.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$99256.0 through Sep 2019, down 237.79% year-over-year, with the annual reading at -$25872.0 for FY2018, 332.21% down from the prior year.
  • Change in Receivables hit -$99256.0 in Q4 2018 for Kraig Biocraft Laboratories, down from -$14744.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $73007.0 in Q2 2018 to a low of -$99256.0 in Q4 2018.
  • Historically, Change in Receivables has averaged $0.0 across 3 years, with a median of $13185.0 in 2016.
  • Biggest YoY gain for Change in Receivables was 147.46% in 2018; the steepest drop was 7252.3% in 2018.
  • Year by year, Change in Receivables stood at $13185.0 in 2016, then crashed by 110.24% to -$1350.0 in 2017, then crashed by 7252.3% to -$99256.0 in 2018.
  • Business Quant data shows Change in Receivables for KBLB at -$99256.0 in Q4 2018, -$14744.0 in Q3 2018, and $73007.0 in Q2 2018.